The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Credit: Getty Images Experts weigh in on the ramifications of GLP-1 drug shortages and how they affect patients ... While ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason ...

The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is ...